BioSpace News Archive

Exactech , a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, announced today that, in the largest study of its kind, Exactech’s Equinoxe® shoulder system demonstra

Pieris today announced that members of the management team will participate in the following upcoming investor conferences

BridgeBio Pharma, Inc., a clinical-stage biopharmaceutical company focused on genetic diseases, announced that on September 1, 2020, the compensation committee of BridgeBio’s board of directors granted 10 new employees options to purchase an aggregate of 18,231 shares of the Company’s common stock with a per share exercise price of $27.62 and restricted stock units for an aggregate of 19,915 shares of the Company’s common stock.

In honor of Childhood Cancer Awareness Month, Vionic is pleased to support St. Jude Children’s Research Hospital® and the Pediatric Neuro-Oncology Consortium Foundation, established by Vionic co-founder Bruce Campbell and his wife Allyn.

Genocea Biosciences, Inc. announced that the company will present incremental follow-up data, including additional tumor scan results and detailed immunogenicity data on the first five patients from Part B of the ongoing GEN-009 Phase 1/2 a trial at the European Society for Medical Oncology Virtual Congress 2020 from September 19-21.

Jeffrey L. Wade, Lexicon’s executive vice president, corporate and administrative affairs and chief financial officer, will make a live webcast company presentation for the Wells Fargo conference on Thursday, September 10, 2020 at 2:00 p.m. ET.

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that John Kollins, President and Chief Executive Officer, is scheduled to present at the following conferences in the month of September:

John Wiley & Sons, Inc., a global leader in research and education, announced results for the first quarter ended July 31, 2020.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that CEO Nadav Kidron will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, held virtually this year,

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to study investigational treatments for pa